Surfactant alterations following donation after cardiac death donor lungs

Transplant International

Volumn 24, Issue 1, 2011, Pages 78-84

  Inci, Ilhan ^a   Arni, Stephan ^a   Acevedo, Christa ^b   Jungraithmayr, Wolfgang ^a   Inci, Demet ^c   Vogt, Peter ^d   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

donation after cardiac death; lung transplantation; surface tension; surfactant

Indexed keywords

SURFACTANT;

ADSORPTION KINETICS; AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART DEATH; HISTOLOGY; HISTOPATHOLOGY; LUNG ARTERY PRESSURE; LUNG PRESSURE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NONHUMAN; ORGAN DONOR; OXYGENATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURFACE TENSION; SWINE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DEATH; LUNG; LUNG TRANSPLANTATION; PULMONARY SURFACTANTS; SWINE; TISSUE DONORS; VASCULAR RESISTANCE; WARM ISCHEMIA;

EID: 78650028801     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01154.x     Document Type: Article

References (26)

1. De Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant 2007; 26: 529.
2. Kootstra G,. The asystolic, or non-heart-beating, donor. Transplantation 1997; 15: 63.
3. De Oliveira NC, Osaki S, Maloney JD, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010; 139: 1306.
4. Erasmus ME, Verschuuren EA, Nijkamp DM, Vermeyden JW, Van Der Bij W,. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation 2010; 89: 452.
5. Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant 2009; 28: 753.
6. Snell GI, Levvey BJ, Oto T, et al. Early lung transplantation success utilizing controlled donation after cardiac death donors. Am J Transplant 2008; 8: 1282.
7. Steen S, Söberg T, Pierre L, et al. Transplantation of lungs from a non-hear-beating donor. Lancet 2001; 357: 825.
8. Brackenbury AM, Puligandla PS, McCaig LA, et al. Evaluation of exogenous surfactant in HCL-induced lung injury. Am J Respir Crit Care Med 2001; 163: 1135.
9. Kesecioglu J, Haitsma JJ,. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2006; 12: 55.
10. Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007; 26: 1054.
11. Urabe N, Fujisawa T, Saitoh Y, et al. The capacity of dog lung to release prostaglandin I2 as a biochemical parameter for evaluating lung damage during preservation. Transplantation 1994; 57: 194.
12. Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM III,. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536.
13. Struber M, Fischer S, Niedermeyer J, et al. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial. J Thorac Cardiovasc Surg 2007; 133: 1620.
14. Kermeen FD, McNeil KD, Fraser JF, et al. Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant. J Heart Lung Transplant 2007; 26: 850.
15. Erasmus ME, Hofstede GJ, Petersen AH, Haagsman HP, Oetomo SB, Prop J,. Effects of early surfactant treatment persisting for one week after lung transplantation in rats. Am J Respir Crit Care Med. 1997; 156: 567.
16. Gunther A, Balser M, Schmidt R, et al. Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration. J Thorac Cardiovasc Surg 2004; 127: 344.
17. Van Der Kaaij NP, Haitsma JJ, Kluin J, et al. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung. Eur J Cardiothorac Surg 2005; 27: 774.
18. Boglione M, Morandini M, Barrenechea M, Rubio R, Aguilar D,. Surfactant treatment in a non-heart-beating donor rat lung transplantation model. Transplant Proc 2001; 33: 2554.
19. Nonaka M, Kadokura M, Takaba T,. Effects of initial low flow reperfusion and surfactant administration on the viability of perfused cadaveric rat lungs. Lung 1999; 177: 37.
20. Kutschka I, Sommer SP, Hohlfeld JM, et al. In-situ topical cooling of lung grafts: early graft function and surfactant analysis in a porcine single lung transplant model. Eur J Cardiothorac Surg 2003; 24: 411.
21. Huang TK, Uyehara CF, Balaraman V, et al. Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury. Lung 2004; 182: 15.
22. Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg 2006; 81: 460.
23. Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007; 83: 2191.
24. Egan TM,. Non-heart-beating donors in thoracic transplantation. J Heart Lung Transplant 2004; 23: 3.
25. De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant 2009; 28: 380.
26. Mason DP, Murthy SC, Gonzalez-Stawinski GV, et al. Early experience with lung transplantation using donors after cardiac death. J Heart Lung Transplant 2008; 27: 561.